| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 01/30/2003 | CA2452421A1 Anti-microbial targeting chimeric pharmaceutical |
| 01/29/2003 | EP1279963A1 Protein-target screening method using near-infrared fluorescent dyes |
| 01/29/2003 | EP1279736A1 Methods of RNA and protein synthesis |
| 01/29/2003 | EP1279731A1 Process for the development of binding mini-proteins |
| 01/29/2003 | EP1279678A1 Gag antigen and other orf fragments of lav virus. Use for the detection of lav infection and in immunogenic compositions |
| 01/29/2003 | EP1279332A2 Transgenic non-human mammal |
| 01/29/2003 | EP1278884A1 Immunoglobulin binding protein arrays in plant cells |
| 01/29/2003 | EP1278883A2 E. coli extract for protein synthesis |
| 01/29/2003 | EP1278871A2 Human phospholipase c delta 5 |
| 01/29/2003 | EP1278869A2 Proteases |
| 01/29/2003 | EP1278856A2 Immunogenic pneumococcal protein and vaccine compositions thereof |
| 01/29/2003 | EP1278853A2 Listeria monocytogenes genome, polypeptides and uses |
| 01/29/2003 | EP1278851A1 Humanised antibodies to the epidermal growth factor receptor |
| 01/29/2003 | EP1278849A2 Thrombopoietin receptor modulating peptide |
| 01/29/2003 | EP1278848A1 New ras guanine-nucleotide-exchange factor 1 (nrg1) |
| 01/29/2003 | EP1278846A2 Cytoskeleton-associated proteins |
| 01/29/2003 | EP1278843A2 Rna metabolism proteins |
| 01/29/2003 | EP1278842A2 Dna encoding the prost 03 polypeptide |
| 01/29/2003 | EP1278840A2 Isolated human g-protein coupled receptors of the mas proto-oncogene subfamily, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 01/29/2003 | EP1278839A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 01/29/2003 | EP1278838A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 01/29/2003 | EP1278830A2 Identification and uses of a hyaluronan receptor |
| 01/29/2003 | EP1278829A2 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
| 01/29/2003 | EP1278826A1 Novel proteins |
| 01/29/2003 | EP1278778A2 Modified peptides, comprising an fc domain, as therapeutic agents |
| 01/29/2003 | EP1278777A2 G protein coupled receptor (gpcr) agonists and antagonists and methods of activating and inhibiting gpcr using the same |
| 01/29/2003 | EP1278776A2 Isolated human transporter proteins, nucleic acids and uses thereof |
| 01/29/2003 | EP1278775A2 Isolated human g-protein coupled receptors that are members of the aminergic subfamily, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 01/29/2003 | EP1278774A2 Human g-protein coupled receptors |
| 01/29/2003 | EP1278772A2 Glucagon antagonists |
| 01/29/2003 | EP1278770A1 Human wingless-like gene |
| 01/29/2003 | EP1278766A2 Polynucleotides for diagnosing mammary gland cancer |
| 01/29/2003 | EP1278534A1 Methods and compositions for impairing multiplication of hiv-1 |
| 01/29/2003 | EP1002110B1 Immune responses against hpv antigens elicited by compositions comprising an hpv antigen and a stress protein or an expression vector capable of expression of these proteins |
| 01/29/2003 | EP0858465B1 Anti-tumoral protein |
| 01/29/2003 | EP0703980B1 Intracellular binding proteins and use thereof |
| 01/29/2003 | CN1394138A Hair growth stimulant |
| 01/29/2003 | CN1393475A Micromolecular lung cancer antibody targeted immunotoxin and its equipment, preparing process and usage |
| 01/28/2003 | WO2002010370A1 Process for producing recombined protein |
| 01/28/2003 | US6512104 Interleukin-1β converting enzyme like cysteine protease |
| 01/28/2003 | US6512103 Mammalian chemokine reagents |
| 01/28/2003 | US6512097 Chimeric molecules that specifically bind a tumor cell bearing a c-erbB-2; immunotherapy |
| 01/28/2003 | US6512096 Prostate cell surface antigen-specific antibodies |
| 01/28/2003 | US6511962 Intermediates useful for synthesizing laspartomycin derivatives as well as the laspartomycin derivatives |
| 01/28/2003 | US6511957 Corneocyte envelope protein or polypeptide in an amount sufficient to provide a protective layer on said skin, hair or nails |
| 01/28/2003 | US6511840 Share structural similarity with animal kinases, including, but not limited to myosin kinases |
| 01/28/2003 | US6511829 Combine the inherent strong visible fluorescent properties of GFPs with the anionic phospholipid binding specificity of annexins; selectively labeling apoptotic cells |
| 01/28/2003 | US6511827 Nucleotide encoding human galanin receptor 3 (GALR3) |
| 01/28/2003 | US6511826 For use in diagnosis therapy |
| 01/28/2003 | US6511823 Novel DNA and amino acid sequences; expression vectors and host cells useful in a method for production of the HBNF protein |
| 01/28/2003 | CA2417572A1 Process for producing recombined protein |
| 01/23/2003 | WO2003006667A2 Method for preparing lipid ii and use of the lipid ii thus obtained |
| 01/23/2003 | WO2003006649A2 Expression system |
| 01/23/2003 | WO2003006609A2 Human cytokine receptor |
| 01/23/2003 | WO2003006607A2 Inhibition of apoptosis process and improvement of cell performance |
| 01/23/2003 | WO2003006606A2 Targeted fusion proteins and methods for the characterization of cellular membrane domains |
| 01/23/2003 | WO2003006531A1 Keratin-based products and methods for their productions |
| 01/23/2003 | WO2003006507A1 Method of preparing antinarcotic shellfish toxin antibody, novel antibody, elisa kit with the use of the antibody and labelled toxin sample prepared by the method |
| 01/23/2003 | WO2003006506A2 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 01/23/2003 | WO2003006505A1 Factor viii separation |
| 01/23/2003 | WO2003006499A2 Survivin interacting protein tpr1 |
| 01/23/2003 | WO2003006493A2 Histidine phosphatase interacting protein with 180kd |
| 01/23/2003 | WO2003006056A2 End-locked five-helix protein |
| 01/23/2003 | WO2003005953A2 Viral proteins capable of binding lar |
| 01/23/2003 | WO2002088302A3 Method for secreting proteins by bacteria, leader sequences and vectors for carrying out said method |
| 01/23/2003 | WO2002086058A3 Method for producing catalytic antibodies (variants), antigens for immunisation and nucleotide sequence |
| 01/23/2003 | WO2002080842A3 Medicament and method for diagnosing an autoimmune condition_in particular psoriasis |
| 01/23/2003 | WO2002066509A3 Treatment involving dkk-1 or antagonists thereof |
| 01/23/2003 | WO2002046364A9 Genes associated with mechanical stress, expression products therefrom, and uses thereof |
| 01/23/2003 | WO2002034921A3 FERMENTATIVE PRODUCTION OF D-p-HYDROXYPHENYLGLYCINE AND D-PHENYLGLYCINE |
| 01/23/2003 | WO2002029059A3 Nogo receptor homologs |
| 01/23/2003 | WO2002020619A3 HUMAN ANTIBODIES AGAINST PSEUDOMONAS AERUGINOSA LPS DERIVED FROM TRANSGENIC XENOMOUSE$m(3) |
| 01/23/2003 | WO2002020569A3 Mammalian genes; related reagents and methods |
| 01/23/2003 | WO2002010405A3 A human disintegrin protein |
| 01/23/2003 | WO2002010363A3 Protein phosphatases |
| 01/23/2003 | WO2002008293A3 Multivalent target binding protein |
| 01/23/2003 | WO2001072768A3 Single chain class i major histo-compatibility complexes, constructs encoding same and methods of generating same |
| 01/23/2003 | WO2001066568A3 Use of recombinant antigens to determine the immune status of an animal |
| 01/23/2003 | US20030018181 Antiinflammatory agents; culturing; isolation of fusion protein |
| 01/23/2003 | US20030018180 Secreted protein HFEAF41 |
| 01/23/2003 | US20030018178 Genes encoding mycobacterial proteins associated with cell binding and cell entry and uses thereof |
| 01/23/2003 | US20030018170 Mono-specific polyclonal antibodies and methods for detecting Clostridium difficile Toxin A |
| 01/23/2003 | US20030018168 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/23/2003 | US20030017984 Binding to ligand; crystallization; cardiovascular disorders; Alzheimer's disease |
| 01/23/2003 | US20030017982 Genetic engineering; hybrid nucleic acids |
| 01/23/2003 | US20030017981 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/23/2003 | US20030017973 Fraction extracted from archaebacteria for cosmetic purposes |
| 01/23/2003 | US20030017618 Apparatus for use in the detection of preferential particles in sample |
| 01/23/2003 | US20030017617 Mammalian receptor proteins; related reagents and methods |
| 01/23/2003 | US20030017585 Polypeptide for use in the treatment of cancer, nervous system and autoimmune disorders |
| 01/23/2003 | US20030017571 Polynucleotide compositions encoding broad spectrum delta-endotoxins |
| 01/23/2003 | US20030017570 Chitinase materials and methods |
| 01/23/2003 | US20030017563 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/23/2003 | US20030017562 Nucleotide sequences coding polypetide for use in the treatment, prevention and diagnosis of gastrointestinal and apoptosis disorders |
| 01/23/2003 | US20030017550 Nucleotide sequences coding polypeptide for use in the treatment of viral, neoplastic, multiple sclerosis and immunological disorders |
| 01/23/2003 | US20030017548 Proteins for use in treatment of gastrointestinal disorders |
| 01/23/2003 | US20030017547 Nucleotide sequences coding polypeptide for use in the treatment of cancer |
| 01/23/2003 | US20030017537 Amplified genetic expression of genetically engineered hemoglobin; obtain cell, transform with vector coding genetically engineered hemoglobin, express vector, recover hemoglobin |
| 01/23/2003 | US20030017535 Nucleotide sequences coding polypeptide for use in the prevention and treatment of atherosclerosis, cardiovascular and cancerous disorders |
| 01/23/2003 | US20030017531 Preparation of a recombinant protein in a prokaryotic host cell |